Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Jay Olson is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/16/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/16/2024 | RVMD | Buy Now | Revolution Medicines | $46.73 | 17.7% | $45 → $55 | Maintains | Outperform | Get Alert |
| 06/18/2024 | EDIT | Buy Now | Editas Medicine | $5.70 | 110.53% | $12 → $12 | Maintains | Perform | Get Alert |
| 06/10/2024 | GLTO | Buy Now | Galecto | $0.60 | 1400% | $10 → $9 | Maintains | Outperform | Get Alert |
| 05/15/2024 | VYGR | Buy Now | Voyager Therapeutics | $9.15 | 96.72% | → $18 | Maintains | Outperform | Get Alert |
| 05/15/2024 | STRO | Buy Now | Sutro Biopharma | $4.13 | 141.84% | $10 → $10 | Maintains | Outperform | Get Alert |
| 05/10/2024 | CRSP | Buy Now | CRISPR Therapeutics | $62.76 | 51.38% | $102 → $95 | Maintains | Outperform | Get Alert |
| 05/06/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.64 | 1.9% | $19 → $19 | Maintains | Perform | Get Alert |
| 05/02/2024 | NBIX | Buy Now | Neurocrine Biosciences | $148.24 | 45.71% | $200 → $216 | Maintains | Outperform | Get Alert |
| 04/29/2024 | BIIB | Buy Now | Biogen | $221.49 | 21.9% | $270 → $270 | Maintains | Outperform | Get Alert |
| 04/24/2024 | NBIX | Buy Now | Neurocrine Biosciences | $148.24 | 34.92% | $200 → $200 | Maintains | Outperform | Get Alert |
| 04/24/2024 | INCY | Buy Now | Incyte | $63.80 | 31.66% | $92 → $84 | Maintains | Outperform | Get Alert |
| 04/19/2024 | BIIB | Buy Now | Biogen | $221.49 | 21.9% | $290 → $270 | Maintains | Outperform | Get Alert |
| 04/18/2024 | SAGE | Buy Now | Sage Therapeutics | $11.98 | 41.9% | $25 → $17 | Maintains | Perform | Get Alert |
| 04/12/2024 | RVMD | Buy Now | Revolution Medicines | $46.73 | -3.7% | $43 → $45 | Maintains | Outperform | Get Alert |
| 04/12/2024 | SKYE | Buy Now | Skye Bioscience | $6.40 | 290.63% | → $25 | Initiates | → Outperform | Get Alert |
| 04/11/2024 | QTTB | Buy Now | Q32 Bio | $26.41 | 89.29% | → $50 | Initiates | → Outperform | Get Alert |
| 04/09/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $50.25 | 49.25% | $72 → $75 | Maintains | Outperform | Get Alert |
| 04/03/2024 | STRO | Buy Now | Sutro Biopharma | $4.13 | 141.84% | $10 → $10 | Maintains | Outperform | Get Alert |
| 03/28/2024 | STRO | Buy Now | Sutro Biopharma | $4.13 | 141.84% | → $10 | Maintains | Outperform | Get Alert |
| 03/27/2024 | VKTX | Buy Now | Viking Therapeutics | $57.40 | 140.42% | $116 → $138 | Maintains | Outperform | Get Alert |
| 03/27/2024 | STRO | Buy Now | Sutro Biopharma | $4.13 | 141.84% | $10 → $10 | Maintains | Outperform | Get Alert |
| 03/27/2024 | CGTX | Buy Now | Cognition Therapeutics | $1.95 | 361.54% | $9 → $9 | Maintains | Outperform | Get Alert |
| 03/26/2024 | VKTX | Buy Now | Viking Therapeutics | $57.40 | 140.42% | $116 → $138 | Maintains | Outperform | Get Alert |
| 03/15/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $278.22 | 34.79% | $320 → $375 | Maintains | Outperform | Get Alert |
| 03/13/2024 | NBIX | Buy Now | Neurocrine Biosciences | $148.24 | 34.92% | $170 → $200 | Maintains | Outperform | Get Alert |
| 03/12/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.64 | 1.9% | $25 → $19 | Maintains | Perform | Get Alert |
| 03/07/2024 | MRNS | Buy Now | Marinus Pharma | $1.41 | 538.3% | $9 → $9 | Maintains | Perform | Get Alert |
| 03/07/2024 | JSPR | Buy Now | Jasper Therapeutics | $19.92 | 301.61% | $80 → $80 | Maintains | Outperform | Get Alert |
| 03/06/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $50.25 | 43.28% | $65 → $72 | Maintains | Outperform | Get Alert |
| 03/05/2024 | IMRX | Buy Now | Immuneering | $1.22 | 1949.18% | $25 → $25 | Reiterates | Outperform → Outperform | Get Alert |
| 03/05/2024 | ETNB | Buy Now | 89bio | $9.16 | — | — | Maintains | Perform | Get Alert |
| 03/01/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $278.22 | 15.02% | $300 → $320 | Maintains | Outperform | Get Alert |
| 02/28/2024 | VKTX | Buy Now | Viking Therapeutics | $57.40 | 102.09% | $46 → $116 | Maintains | Outperform | Get Alert |
| 02/26/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $50.25 | 29.35% | $63 → $65 | Reinstates | → Outperform | Get Alert |
| 02/20/2024 | PRTA | Buy Now | Prothena Corp | $23.95 | 234.03% | $98 → $80 | Maintains | Outperform | Get Alert |
| 02/14/2024 | BIIB | Buy Now | Biogen | $221.49 | 30.93% | $295 → $290 | Maintains | Outperform | Get Alert |
| 02/05/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.64 | 34.08% | → $25 | Reiterates | Perform → Perform | Get Alert |
| 02/01/2024 | AMGN | Buy Now | Amgen | $333.69 | 4.89% | → $350 | Reiterates | Outperform → Outperform | Get Alert |
| 01/30/2024 | BIIB | Buy Now | Biogen | $221.49 | 33.19% | → $295 | Reiterates | Outperform → Outperform | Get Alert |
| 12/18/2023 | BIIB | Buy Now | Biogen | $221.49 | 33.19% | $280 → $295 | Maintains | Outperform | Get Alert |
| 11/30/2023 | BIVI | Buy Now | BioVie | $0.44 | 1045.34% | $12 → $5 | Maintains | Outperform | Get Alert |
| 11/22/2023 | ENTA | Buy Now | Enanta Pharma | $16.21 | 29.55% | $25 → $21 | Maintains | Perform | Get Alert |
| 11/13/2023 | NTLA | Buy Now | Intellia Therapeutics | $27.33 | 156.13% | $80 → $70 | Maintains | Outperform | Get Alert |
| 10/25/2023 | AMGN | Buy Now | Amgen | $333.69 | -7.1% | $300 → $310 | Maintains | Outperform | Get Alert |
| 10/23/2023 | RVMD | Buy Now | Revolution Medicines | $46.73 | -7.98% | $40 → $43 | Maintains | Outperform | Get Alert |
| 10/20/2023 | AMGN | Buy Now | Amgen | $333.69 | -10.1% | $290 → $300 | Maintains | Outperform | Get Alert |
| 10/09/2023 | AMGN | Buy Now | Amgen | $333.69 | -13.09% | $280 → $290 | Maintains | Outperform | Get Alert |
| 10/06/2023 | NBIX | Buy Now | Neurocrine Biosciences | $148.24 | 11.31% | $160 → $165 | Maintains | Outperform | Get Alert |
| 10/06/2023 | IMGN | Buy Now | Immunogen | — | — | → $16 | Initiates | → Perform | Get Alert |
| 10/06/2023 | STRO | Buy Now | Sutro Biopharma | $4.13 | 141.84% | → $10 | Initiates | → Outperform | Get Alert |
| 08/22/2023 | EXEL | Buy Now | Exelixis | $22.80 | 27.22% | $25 → $29 | Maintains | Outperform | Get Alert |
| 08/21/2023 | NBIX | Buy Now | Neurocrine Biosciences | $148.24 | 3.89% | $150 → $154 | Maintains | Outperform | Get Alert |
| 08/11/2023 | MRNS | Buy Now | Marinus Pharma | $1.41 | 892.91% | → $14 | Downgrade | Outperform → Perform | Get Alert |
| 08/10/2023 | CRSP | Buy Now | CRISPR Therapeutics | $62.76 | 62.54% | → $102 | Reiterates | Outperform → Outperform | Get Alert |
| 08/09/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | $56 → $62 | Maintains | Outperform | Get Alert |
| 08/09/2023 | MDGL | Buy Now | Madrigal Pharmaceuticals | $278.22 | 2.44% | $350 → $285 | Maintains | Outperform | Get Alert |
| 08/09/2023 | ENTA | Buy Now | Enanta Pharma | $16.21 | 54.23% | $30 → $25 | Maintains | Perform | Get Alert |
| 08/08/2023 | SAGE | Buy Now | Sage Therapeutics | $11.98 | 66.94% | $24 → $20 | Maintains | Perform | Get Alert |
| 08/07/2023 | VYGR | Buy Now | Voyager Therapeutics | $9.15 | 74.86% | → $16 | Reiterates | Outperform → Outperform | Get Alert |
| 08/07/2023 | BIIB | Buy Now | Biogen | $221.49 | 30.93% | $360 → $290 | Maintains | Outperform | Get Alert |
| 08/07/2023 | SAGE | Buy Now | Sage Therapeutics | $11.98 | — | — | Downgrade | Outperform → Perform | Get Alert |
| 08/03/2023 | EDIT | Buy Now | Editas Medicine | $5.70 | 110.53% | → $12 | Reiterates | Perform → Perform | Get Alert |
| 08/03/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.64 | 34.08% | → $25 | Reiterates | Perform → Perform | Get Alert |
| 08/02/2023 | RVMD | Buy Now | Revolution Medicines | $46.73 | -14.4% | $35 → $40 | Maintains | Outperform | Get Alert |
| 08/02/2023 | NBIX | Buy Now | Neurocrine Biosciences | $148.24 | 1.19% | → $150 | Reiterates | Outperform → Outperform | Get Alert |
| 08/02/2023 | INCY | Buy Now | Incyte | $63.80 | 44.2% | → $92 | Reiterates | Outperform → Outperform | Get Alert |
| 08/01/2023 | GLTO | Buy Now | Galecto | $0.60 | 1900% | → $12 | Reiterates | Outperform → Outperform | Get Alert |
| 07/31/2023 | EXEL | Buy Now | Exelixis | $22.80 | 9.67% | → $25 | Reiterates | Outperform → Outperform | Get Alert |
| 07/28/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.64 | 34.08% | $23 → $25 | Maintains | Perform | Get Alert |
| 07/25/2023 | AMGN | Buy Now | Amgen | $333.69 | -16.09% | → $280 | Reiterates | Outperform → Outperform | Get Alert |
| 07/14/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.64 | 23.36% | $20 → $23 | Maintains | Perform | Get Alert |
| 06/20/2023 | GLTO | Buy Now | Galecto | $0.60 | 1900% | → $12 | Initiates | → Outperform | Get Alert |
| 06/12/2023 | BIIB | Buy Now | Biogen | $221.49 | 62.54% | $350 → $360 | Maintains | Outperform | Get Alert |
| 06/06/2023 | DNLI | Buy Now | Denali Therapeutics | $23.93 | 184.16% | $70 → $68 | Maintains | Outperform | Get Alert |
| 05/18/2023 | AMGN | Buy Now | Amgen | $333.69 | -16.09% | → $280 | Reiterates | Outperform → Outperform | Get Alert |
| 05/17/2023 | BIVI | Buy Now | BioVie | $0.44 | 2648.83% | → $12 | Reiterates | Outperform → Outperform | Get Alert |
| 05/16/2023 | VKTX | Buy Now | Viking Therapeutics | $57.40 | -30.31% | $35 → $40 | Maintains | Outperform | Get Alert |
| 05/16/2023 | JSPR | Buy Now | Jasper Therapeutics | $19.92 | -59.84% | → $80 | Reinstates | Outperform → Outperform | Get Alert |
| 05/16/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $14 → $16 | Maintains | Outperform | Get Alert |
| 05/16/2023 | MDGL | Buy Now | Madrigal Pharmaceuticals | $278.22 | 25.8% | $300 → $350 | Maintains | Outperform | Get Alert |
| 05/11/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $60 | Reiterates | Perform → Perform | Get Alert |
| 05/11/2023 | ENTA | Buy Now | Enanta Pharma | $16.21 | 85.07% | $50 → $30 | Reiterates | Perform → Perform | Get Alert |
| 05/11/2023 | ETNB | Buy Now | 89bio | $9.16 | 227.51% | → $30 | Reiterates | Outperform → Outperform | Get Alert |
| 05/09/2023 | RVMD | Buy Now | Revolution Medicines | $46.73 | -25.1% | → $35 | Reiterates | → Outperform | Get Alert |
| 05/09/2023 | EDIT | Buy Now | Editas Medicine | $5.70 | 110.53% | → $12 | Reiterates | → Perform | Get Alert |
| 05/09/2023 | CGTX | Buy Now | Cognition Therapeutics | $1.95 | 361.54% | → $9 | Reiterates | → Outperform | Get Alert |
| 05/08/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | → $280 | Reiterates | → Outperform | Get Alert |
| 05/08/2023 | NTLA | Buy Now | Intellia Therapeutics | $27.33 | 229.31% | $93 → $90 | Maintains | Outperform | Get Alert |
| 05/08/2023 | BCYC | Buy Now | Bicycle Therapeutics | $22.60 | 143.36% | → $55 | Reiterates | → Outperform | Get Alert |
| 05/02/2023 | NBIX | Buy Now | Neurocrine Biosciences | $148.24 | 1.19% | → $150 | Reiterates | → Outperform | Get Alert |
| 04/27/2023 | VKTX | Buy Now | Viking Therapeutics | $57.40 | -39.02% | → $35 | Reiterates | → Outperform | Get Alert |
| 04/26/2023 | BIIB | Buy Now | Biogen | $221.49 | 46.73% | $310 → $325 | Maintains | Outperform | Get Alert |
| 04/25/2023 | MRNS | Buy Now | Marinus Pharma | $1.41 | 892.91% | $12 → $14 | Maintains | Outperform | Get Alert |
| 04/25/2023 | VKTX | Buy Now | Viking Therapeutics | $57.40 | -39.02% | $30 → $35 | Maintains | Outperform | Get Alert |
| 04/24/2023 | AMGN | Buy Now | Amgen | $333.69 | -13.09% | $292 → $290 | Maintains | Outperform | Get Alert |
| 03/28/2023 | VKTX | Buy Now | Viking Therapeutics | $57.40 | -47.74% | $20 → $30 | Maintains | Outperform | Get Alert |
| 03/24/2023 | CGTX | Buy Now | Cognition Therapeutics | $1.95 | 361.54% | → $9 | Reiterates | → Outperform | Get Alert |
| 03/14/2023 | SGEN | Buy Now | Seagen | — | — | $210 → $229 | Maintains | Outperform | Get Alert |
| 03/10/2023 | VYGR | Buy Now | Voyager Therapeutics | $9.15 | 53.01% | → $14 | Initiates | → Outperform | Get Alert |
| 03/07/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $10 → $12 | Maintains | Outperform | Get Alert |
| 03/06/2023 | NKTR | Buy Now | Nektar Therapeutics | $1.48 | 102.7% | $5 → $3 | Maintains | Perform | Get Alert |
| 03/02/2023 | DNLI | Buy Now | Denali Therapeutics | $23.93 | 192.52% | $85 → $70 | Maintains | Outperform | Get Alert |
| 03/01/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.64 | 7.27% | $17 → $20 | Maintains | Perform | Get Alert |
| 02/28/2023 | SGEN | Buy Now | Seagen | — | — | $180 → $210 | Maintains | Outperform | Get Alert |
| 02/28/2023 | RVMD | Buy Now | Revolution Medicines | $46.73 | -25.1% | $30 → $35 | Maintains | Outperform | Get Alert |
| 02/27/2023 | MDGL | Buy Now | Madrigal Pharmaceuticals | $278.22 | 7.83% | $250 → $300 | Maintains | Outperform | Get Alert |
| 02/24/2023 | NTLA | Buy Now | Intellia Therapeutics | $27.33 | 240.29% | $115 → $93 | Maintains | Outperform | Get Alert |
| 02/23/2023 | CRSP | Buy Now | CRISPR Therapeutics | $62.76 | 62.63% | $110 → $102.06 | Maintains | Outperform | Get Alert |
| 02/21/2023 | SGEN | Buy Now | Seagen | — | — | $178 → $180 | Maintains | Outperform | Get Alert |
| 02/21/2023 | ETNB | Buy Now | 89bio | $9.16 | 96.51% | $12 → $18 | Maintains | Outperform | Get Alert |
| 02/17/2023 | SGEN | Buy Now | Seagen | — | — | $178 → $180 | Maintains | Outperform | Get Alert |
| 02/16/2023 | BIIB | Buy Now | Biogen | $221.49 | 39.96% | $320 → $310 | Maintains | Outperform | Get Alert |
| 02/15/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.64 | -8.82% | $16 → $17 | Maintains | Perform | Get Alert |
| 02/14/2023 | BIVI | Buy Now | BioVie | $0.44 | 2648.83% | → $12 | Reiterates | → Outperform | Get Alert |
| 02/14/2023 | FREQ | Buy Now | Frequency Therapeutics | — | — | — | Downgrade | Outperform → Perform | Get Alert |
| 02/10/2023 | SGEN | Buy Now | Seagen | — | — | $188 → $178 | Maintains | Outperform | Get Alert |
| 02/01/2023 | AMGN | Buy Now | Amgen | $333.69 | -11.89% | $312 → $294 | Maintains | Outperform | Get Alert |
| 12/20/2022 | MDGL | Buy Now | Madrigal Pharmaceuticals | $278.22 | -10.14% | $170 → $250 | Maintains | Outperform | Get Alert |
| 12/08/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | $85 → $60 | Maintains | Perform | Get Alert |
| 12/06/2022 | AMGN | Buy Now | Amgen | $333.69 | -7.1% | $300 → $310 | Maintains | Outperform | Get Alert |
| 11/29/2022 | CINC | Buy Now | CinCor Pharma | — | — | — | Downgrade | Outperform → Perform | Get Alert |
| 11/18/2022 | EDIT | Buy Now | Editas Medicine | $5.70 | 110.53% | $28 → $12 | Downgrade | Outperform → Perform | Get Alert |
| 11/14/2022 | JSPR | Buy Now | Jasper Therapeutics | $19.92 | -59.84% | $210 → $80 | Maintains | Outperform | Get Alert |
| 11/14/2022 | BIIB | Buy Now | Biogen | $221.49 | 42.22% | $300 → $315 | Maintains | Outperform | Get Alert |
| 10/31/2022 | AYLA | Buy Now | Ayala Pharmaceuticals | — | — | — | Downgrade | Outperform → Perform | Get Alert |
| 10/28/2022 | SGEN | Buy Now | Seagen | — | — | $208 → $188 | Maintains | Outperform | Get Alert |
| 10/21/2022 | RVMD | Buy Now | Revolution Medicines | $46.73 | -35.8% | → $30 | Initiates | → Outperform | Get Alert |
| 10/13/2022 | RLMD | Buy Now | Relmada Therapeutics | $3.81 | — | — | Downgrade | Outperform → Perform | Get Alert |
| 09/29/2022 | PRTA | Buy Now | Prothena Corp | $23.95 | 359.29% | $100 → $110 | Maintains | Outperform | Get Alert |
| 08/10/2022 | ENTA | Buy Now | Enanta Pharma | $16.21 | 263.97% | $53 → $59 | Maintains | Perform | Get Alert |
| 08/01/2022 | ENTA | Buy Now | Enanta Pharma | $16.21 | 226.96% | $45 → $53 | Maintains | Perform | Get Alert |
| 07/21/2022 | CINC | Buy Now | CinCor Pharma | — | — | $30 → $35 | Maintains | Outperform | Get Alert |
| 07/18/2022 | BIIB | Buy Now | Biogen | $221.49 | 3.84% | $225 → $230 | Maintains | Outperform | Get Alert |
| 06/30/2022 | ETNB | Buy Now | 89bio | $9.16 | 63.76% | $40 → $15 | Maintains | Outperform | Get Alert |
| 06/23/2022 | CRSP | Buy Now | CRISPR Therapeutics | $62.76 | 94.41% | $150 → $122 | Maintains | Outperform | Get Alert |
| 06/21/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.64 | 1.9% | $23 → $19 | Maintains | Perform | Get Alert |
| 06/21/2022 | SGEN | Buy Now | Seagen | — | — | $160 → $208 | Maintains | Outperform | Get Alert |
| 06/01/2022 | AMGN | Buy Now | Amgen | $333.69 | -13.09% | $285 → $290 | Maintains | Outperform | Get Alert |
| 05/20/2022 | ENTA | Buy Now | Enanta Pharma | $16.21 | 177.61% | $70 → $45 | Maintains | Outperform | Get Alert |
| 05/13/2022 | ETNB | Buy Now | 89bio | $9.16 | 336.68% | $49 → $40 | Maintains | Outperform | Get Alert |
| 05/11/2022 | CRSP | Buy Now | CRISPR Therapeutics | $62.76 | 139.02% | $172 → $150 | Maintains | Outperform | Get Alert |
| 05/10/2022 | MDGL | Buy Now | Madrigal Pharmaceuticals | $278.22 | -38.9% | $180 → $170 | Maintains | Outperform | Get Alert |
| 05/09/2022 | NTLA | Buy Now | Intellia Therapeutics | $27.33 | 375.67% | $160 → $130 | Maintains | Outperform | Get Alert |
| 05/09/2022 | RLMD | Buy Now | Relmada Therapeutics | $3.81 | 1582% | $75 → $64 | Maintains | Outperform | Get Alert |
| 05/04/2022 | BIIB | Buy Now | Biogen | $221.49 | 1.58% | $240 → $225 | Maintains | Outperform | Get Alert |
| 04/14/2022 | SRRA | Buy Now | Sierra Oncology | — | — | $45 → $55 | Downgrade | Outperform → Perform | Get Alert |
| 04/08/2022 | BIIB | Buy Now | Biogen | $221.49 | 8.36% | $285 → $240 | Maintains | Outperform | Get Alert |
| 03/30/2022 | AYLA | Buy Now | Ayala Pharmaceuticals | — | — | $25 → $16 | Maintains | Outperform | Get Alert |
| 03/15/2022 | BIVI | Buy Now | BioVie | $0.44 | 1961.62% | → $9 | Initiates | → Outperform | Get Alert |
| 03/14/2022 | SRRA | Buy Now | Sierra Oncology | — | — | $38 → $45 | Maintains | Outperform | Get Alert |
| 03/09/2022 | NKTR | Buy Now | Nektar Therapeutics | $1.48 | 1318.92% | → $21 | Upgrade | Perform → Outperform | Get Alert |
| 02/25/2022 | EDIT | Buy Now | Editas Medicine | $5.70 | 864.91% | $80 → $55 | Maintains | Outperform | Get Alert |
| 02/09/2022 | AMGN | Buy Now | Amgen | $333.69 | -14.59% | $272 → $285 | Maintains | Outperform | Get Alert |
| 02/07/2022 | NTLA | Buy Now | Intellia Therapeutics | $27.33 | 448.85% | $145 → $150 | Upgrade | Perform → Outperform | Get Alert |
| 02/01/2022 | CINC | Buy Now | CinCor Pharma | — | — | → $30 | Initiates | → Outperform | Get Alert |
| 12/22/2021 | BIIB | Buy Now | Biogen | $221.49 | 58.02% | $390 → $350 | Maintains | Outperform | Get Alert |
| 12/09/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.64 | 23.36% | — | Maintains | Perform | Get Alert |
| 12/08/2021 | NBIX | Buy Now | Neurocrine Biosciences | $148.24 | 3.89% | — | Maintains | Outperform | Get Alert |
| 12/07/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.64 | 23.36% | — | Maintains | Perform | Get Alert |
| 11/24/2021 | ENTA | Buy Now | Enanta Pharmaceuticals | $16.21 | 350.34% | — | Maintains | Perform | Get Alert |
| 10/13/2021 | JSPR | Buy Now | Jasper Therapeutics | $19.92 | 5.42% | → $210 | Initiates | → Outperform | Get Alert |
| 03/24/2021 | FREQ | Buy Now | Frequency Therapeutics | — | — | $3400 → $1000 | Maintains | Outperform | Get Alert |
| 07/14/2020 | FREQ | Buy Now | Frequency Therapeutics | — | — | → $1800 | Initiates | → Outperform | Get Alert |
